Reengineering Inducible Cardiac-Specific Transgenesis With an Attenuated Myosin Heavy Chain Promoter
暂无分享,去创建一个
Q. Liang | M. Hanks | J. Robbins | A. Sanbe | J. Gulick | H. Osińska | Qiangrong Liang
[1] H. Eldar-Finkelman. Glycogen synthase kinase 3: an emerging therapeutic target. , 2002, Trends in molecular medicine.
[2] E. Olson,et al. Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[3] S. Patel,et al. Absence of cardiac lipid accumulation in transgenic mice with heart-specific HSL overexpression. , 2001, American journal of physiology. Endocrinology and metabolism.
[4] M. Crackower,et al. Temporally Regulated and Tissue-Specific Gene Manipulations in the Adult and Embryonic Heart Using a Tamoxifen-Inducible Cre Protein , 2001, Circulation research.
[5] J. McDonald,et al. Codon optimization markedly improves doxycycline regulated gene expression in the mouse heart , 2001, Transgenic Research.
[6] P. Carmeliet,et al. A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects. , 2001, Development.
[7] Hermann Bujard,et al. Tetracycline-regulated gene expression in the brain , 2000, Current Opinion in Neurobiology.
[8] K. Chien. Genomic circuits and the integrative biology of cardiac diseases , 2000, Nature.
[9] S. R. Grant,et al. Tetracycline-inducible CaM kinase II silences hypertrophy-sensitive gene expression in rat neonate cardiomyocytes. , 2000, Biochemical and biophysical research communications.
[10] M. T. Hasan,et al. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[11] H. Bujard. Controlling genes with tetracyclines , 1999, The journal of gene medicine.
[12] J. Lorenz,et al. Abnormal Cardiac Structure and Function in Mice Expressing Nonphosphorylatable Cardiac Regulatory Myosin Light Chain 2* , 1999, The Journal of Biological Chemistry.
[13] B. Conklin,et al. Conditional expression and signaling of a specifically designed Gi-coupled receptor in transgenic mice , 1999, Nature Biotechnology.
[14] S. Izumo,et al. Cardiac transgenic and gene-targeted mice as models of cardiac hypertrophy and failure: a problem of (new) riches. , 1998, Journal of cardiac failure.
[15] K. Chien,et al. Ventricular muscle-restricted targeting of the RXRalpha gene reveals a non-cell-autonomous requirement in cardiac chamber morphogenesis. , 1998, Development.
[16] G. Fishman,et al. Expression of protein kinase C beta in the heart causes hypertrophy in adult mice and sudden death in neonates. , 1997, The Journal of clinical investigation.
[17] J. Robbins. Altering Cardiac Function via Transgenesis A Nuts and Bolts Approach. , 1997, Trends in cardiovascular medicine.
[18] M. Gossen,et al. Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential. , 1997, Nucleic acids research.
[19] C. Liew,et al. A conserved GATA motif in a tissue-specific DNase I hypersensitive site of the cardiac alpha-myosin heavy chain gene. , 1997, The Biochemical journal.
[20] T. Hewett,et al. Transgenic remodeling of the regulatory myosin light chains in the mammalian heart. , 1997, Circulation research.
[21] G. Fishman,et al. Conditional transgene expression in the heart. , 1996, Circulation research.
[22] J. Fewell,et al. Transgenic remodeling of the contractile apparatus in the mammalian heart. , 1996, Circulation research.
[23] H. Rindt,et al. Anin vivo analysis of transcriptional elements in the mouse α-myosin heavy chain gene promoter , 1995, Transgenic Research.
[24] M. Gossen,et al. Efficacy of tetracycline-controlled gene expression is influenced by cell type: commentary. , 1995, BioTechniques.
[25] M. Gossen,et al. Transcriptional activation by tetracyclines in mammalian cells. , 1995, Science.
[26] M. Gossen,et al. Inducible gene expression systems for higher eukaryotic cells. , 1994, Current opinion in biotechnology.
[27] M. Gossen,et al. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[28] J. Molkentin,et al. Transcription factor GATA-4 regulates cardiac muscle-specific expression of the alpha-myosin heavy-chain gene , 1994, Molecular and cellular biology.
[29] J. Robbins,et al. Murine pulmonary myocardium: Developmental analysis of cardiac gene expression , 1994, Developmental dynamics : an official publication of the American Association of Anatomists.
[30] M. L. Kaplan,et al. Tetracycline-regulated cardiac gene expression in vivo. , 1994, The Journal of clinical investigation.
[31] J. Robbins,et al. Transgenic analysis of the thyroid-responsive elements in the alpha-cardiac myosin heavy chain gene promoter. , 1993, The Journal of biological chemistry.
[32] I. Grupp,et al. Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart. , 1991, Circulation research.
[33] O. Smithies,et al. Testing an "in-out" targeting procedure for making subtle genomic modifications in mouse embryonic stem cells , 1991, Molecular and cellular biology.
[34] J. Sadoshima,et al. Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development. , 2002, Circulation research.
[35] Hermann Bujard,et al. A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells , 1999, The journal of gene medicine.
[36] S. Tsai,et al. Inducible system designed for future gene therapy. , 1997, Methods in molecular biology.